Does SITAGLIPTIN Cause Pulmonary embolism? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Pulmonary embolism have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.6% of all adverse event reports for SITAGLIPTIN.
119
Reports of Pulmonary embolism with SITAGLIPTIN
0.6%
of all SITAGLIPTIN reports
78
Deaths
116
Hospitalizations
How Dangerous Is Pulmonary embolism From SITAGLIPTIN?
Of the 119 reports, 78 (65.5%) resulted in death, 116 (97.5%) required hospitalization, and 29 (24.4%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which SITAGLIPTIN Alternatives Have Lower Pulmonary embolism Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE